In just over a year since its US Food and Drug Administration (FDA) approval, pirtobrutinib (Jayprica) has become a standard ...

Mantle cell lymphoma tends to grow quickly. When doctors find this type of cancer, it’s usually widespread throughout your body already. This can make treatment more difficult. But doctors have ...

They're both slow-growing, and you treat them the same way. The only difference is where these cancers start: Mantle cell lymphoma (MCL) is a rare and fast-growing cancer. About 6% of all non ...

There are currently dozens of clinical trials examining new ways to treat mantle cell lymphoma (MCL). People can learn about trial recruitment at ClinicalTrials.gov. Research into mantle cell ...

An Enniskillen-based man will this week share his chemotherapy journey in a festival performance to raise funds for cancer ...

AstraZeneca's BTK inhibitor Calquence has become the first drug in the class to be approved by the US FDA as a treatment for adult patients with previously untreated mantle cell lymphoma (MCL ...

Wojciech Jurczak, MD, PhD, ​​discusses the future of B-cell lymphoma therapy, with a focus on Bruton's tyrosine kinase ...

An Enniskillen-based man will this week share his chemotherapy journey in a festival performance to raise funds for cancer ...

DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...